RLAY
Relay Therapeutics Inc
NASDAQ · Biotechnology
$8.92
+0.77 (+9.45%)
Open$8.38
Previous Close$8.15
Day High$9.01
Day Low$8.33
52W High$9.04
52W Low$1.78
Volume—
Avg Volume2.68M
Market Cap1.55B
P/E Ratio—
EPS$-1.75
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+631.3% upside
Current
$8.92
$8.92
Target
$65.23
$65.23
$47.67
$65.23 avg
$99.61
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 12.13M | 8.15M | 248.56M |
| Net Income | -409,699,433 | -247,602,397 | 61.13M |
| Profit Margin | -3,374.7% | -3,206.0% | 24.6% |
| EBITDA | -445,213,188 | -284,013,247 | 104.53M |
| Free Cash Flow | — | — | 79.42M |
| Rev Growth | +48.9% | +48.9% | +14.5% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |